TY - JOUR
T1 - Surgical nodal staging in rhabdomyosarcoma of the bladder and/or prostate with or without nodal or metastatic spread. A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG)
AU - Smeulders, Naima
AU - Gaze, Mark N.
AU - Guérin, Florent
AU - Rogers, Timothy
AU - Terwisscha van Scheltinga, Sheila
AU - DeCorti, Federica
AU - Chisholm, Julia
AU - Slater, Olga
AU - Minard-Colin, Veronique
AU - Coppadoro, Beatrice
AU - Zanetti, Ilaria
AU - Craigie, Ross
AU - Burrieza, Gabriela Guillén
AU - Dall'Igna, Patrizia
AU - Fajardo, Raquel Dávila
AU - Lim, Pei
AU - Chargari, Cyrus
AU - Espenel, Sophie
AU - Luis Huertas, Ana L.
AU - Cho, Alexander
AU - Nguyen, Trung
AU - Rees, Helen
AU - Bisogno, Gianni
AU - Merks, Johannes H.M.
AU - Martelli, Hélène
N1 - Copyright © 2026 The Author(s). Published by Elsevier Inc. All rights reserved.
PY - 2026/4/27
Y1 - 2026/4/27
N2 - Background: Risk stratification of rhabdomyosarcoma (RMS) requires accurate staging, with histological nodal assessment being of critical importance for specific tumour sites. This report explores the value of surgical nodal staging in bladder-prostate rhabdomyosarcoma (BP-RMS). Procedure: Patients with BP-RMS enrolled in the RMS2005 and MTS2008 trials (2005–2016) were reviewed for the staging methodology and outcome. Results: Significant differences in 5-year overall and progression-free survival were observed for the 224 patients with BP-RMS of different Tumour-Node-Metastasis (TNM) stages (p < 0.0001). Nodal staging was by imaging in all but 7/224 (3.1%) patients at presentation. Despite the opportunity for nodal sampling at surgery in 175 patients, no nodes were obtained in 120/175 (68.6%). Nodal sampling at surgery after 4–8 chemotherapy cycles in 48 patients, identified tumour in 6/37 (16.2%) patients considered N0 by imaging (all aged <10 years with favourable histology >5 cm tumours) and observed no tumour in 8/11 (72.7%) deemed N1, prompting changes to local therapy in 9/14 (64.3%). Overall, surgical nodal assessment did not impact on local/nodal progression/relapse (12/55, 21.8%) as compared to staging by imaging alone (29/166, 16.9%, p = 0.548; data missing for 3 patients). Pathological nodal assessment also failed to show benefit on locoregional events for patients with significantly poorer outcome, namely those aged ≥10 years (p = 0.446) or with unfavourable histology (p = 0.613). The specific targeting of nodal basins by radiotherapy showed no impact on outcome (p = 1.000). Conclusions: In contrast to other sites, surgical nodal sampling, undertaken in 24.6% (in 3.1% at diagnosis), does not significantly impact outcome of BP-RMS, despite imaging-pathological discordance prompting changes to treatment for affected patients.
AB - Background: Risk stratification of rhabdomyosarcoma (RMS) requires accurate staging, with histological nodal assessment being of critical importance for specific tumour sites. This report explores the value of surgical nodal staging in bladder-prostate rhabdomyosarcoma (BP-RMS). Procedure: Patients with BP-RMS enrolled in the RMS2005 and MTS2008 trials (2005–2016) were reviewed for the staging methodology and outcome. Results: Significant differences in 5-year overall and progression-free survival were observed for the 224 patients with BP-RMS of different Tumour-Node-Metastasis (TNM) stages (p < 0.0001). Nodal staging was by imaging in all but 7/224 (3.1%) patients at presentation. Despite the opportunity for nodal sampling at surgery in 175 patients, no nodes were obtained in 120/175 (68.6%). Nodal sampling at surgery after 4–8 chemotherapy cycles in 48 patients, identified tumour in 6/37 (16.2%) patients considered N0 by imaging (all aged <10 years with favourable histology >5 cm tumours) and observed no tumour in 8/11 (72.7%) deemed N1, prompting changes to local therapy in 9/14 (64.3%). Overall, surgical nodal assessment did not impact on local/nodal progression/relapse (12/55, 21.8%) as compared to staging by imaging alone (29/166, 16.9%, p = 0.548; data missing for 3 patients). Pathological nodal assessment also failed to show benefit on locoregional events for patients with significantly poorer outcome, namely those aged ≥10 years (p = 0.446) or with unfavourable histology (p = 0.613). The specific targeting of nodal basins by radiotherapy showed no impact on outcome (p = 1.000). Conclusions: In contrast to other sites, surgical nodal sampling, undertaken in 24.6% (in 3.1% at diagnosis), does not significantly impact outcome of BP-RMS, despite imaging-pathological discordance prompting changes to treatment for affected patients.
KW - Bladder
KW - Event-free survival
KW - Nodal staging
KW - Overall survival
KW - Pathological nodal assessment
KW - Prostate
KW - Rhabdomyosarcoma
KW - Risk stratification
KW - Surgical nodal staging
UR - https://www.scopus.com/pages/publications/105038960434
U2 - 10.1016/j.jpedsurg.2026.163162
DO - 10.1016/j.jpedsurg.2026.163162
M3 - Article
C2 - 42055245
AN - SCOPUS:105038960434
SN - 0022-3468
VL - 61
JO - Journal of Pediatric Surgery
JF - Journal of Pediatric Surgery
IS - 7
M1 - 163162
ER -